Linde plc beats Q3 estimates with price rises and efficiency gains

Linde reported Q3 adjusted earnings per share of US $4.21, up 7% year-on-year, aided by higher pricing in industrial-gases markets and cost-cut programmes. The U.S.–German group supplies oxygen, nitrogen and hydrogen to factories and hospitals, and said that margin-improvement initiatives are gaining traction. Management noted that cyclical demand remains moderate but is supported by structural hydrogen and specialised gases. The results comfort investors seeking stable industrial plays amid economic headwinds.